The inhibition of tumor cell proliferation following the expression of AnxA6 in AnxA6-low cells has been shown to be partly due to the inactivation of activated EGFR and the termination of EGFR-mediated activation of the Ras pathway. The gene discussed is ANXA6; the disease is neoplasm.